"Female Viagra" might be the most confusing label in all of sexual medicine, because it gets stuck onto two completely different things. There's the pink pill actually sold under that name — and then there are the drugs the regulators genuinely approved for low desire in women, which most people have never heard of and which work nothing like Viagra at all. Sorting out which is which changes what you'd reasonably expect from each.

The Pink Pill That Borrowed a Name

The "Female Viagra" you can buy is sildenafil — the very same molecule men take for erectile dysfunction. It does what sildenafil does: improves blood flow, which in a woman's case means more genital circulation and engorgement. What it doesn't do is reach into the part of the brain that generates desire, and it has never actually been approved for women. It borrowed Viagra's name because it borrowed Viagra's ingredient, not because it solves the problem most women are asking about.

The Drugs That Actually Got Approved

For low desire specifically — the condition clinicians call hypoactive sexual desire disorder — two medications have genuine FDA approval, and tellingly, neither is a blood-flow drug. Both work on the brain.

Addyi (flibanserin)

Approved in 2015, Addyi is a pill you take every single day at bedtime, not on the night you want it. It nudges brain chemistry — serotonin, dopamine, and norepinephrine — which is why it's often described as behaving more like an antidepressant than like Viagra. It takes a slow four to eight weeks to show any effect, you need to steer clear of alcohol around your dose because the combination can drop blood pressure and cause fainting, and it commonly brings dizziness, drowsiness, and nausea.

Vyleesi (bremelanotide)

Approved in 2019, Vyleesi takes the opposite shape: it's an on-demand self-injection, delivered under the skin with an auto-injector pen about forty-five minutes before intimacy. It activates a different brain system entirely to lift sexual motivation, is capped at eight doses a month, and is notorious for nausea — affecting up to roughly four in ten users — while also nudging blood pressure upward, which calls for caution in anyone with heart concerns.

Why the Difference Matters

The split is really about which problem you're trying to solve. Sildenafil-based "Female Viagra" addresses the physical, plumbing side of the equation — circulation and arousal — whereas Addyi and Vyleesi go after desire at its source in the brain. They're different tools for different problems, and crucially, none of them is the simple "take one and you're in the mood" pill the nickname implies: one demands daily dosing and a no-alcohol rule, the other an injection and a strong chance of nausea. On top of that, low desire has many possible roots — stress, relationships, hormones, other medications, general health — so it genuinely warrants a proper evaluation rather than self-prescribing the pink option and hoping. For a clearer picture of where Female Viagra fits among the options for women, the detailed guide lays out the landscape.

So is Female Viagra the same as Addyi? Not remotely. One is men's sildenafil wearing a new label and working on blood flow; the other is a daily brain-chemistry drug built specifically for women's desire, with a slow burn and an alcohol ban to match. Add Vyleesi's on-demand injection and you have three quite different answers to three slightly different questions. The useful move isn't picking the one with the catchiest name — it's working out, ideally with a doctor, which problem you actually have before deciding which tool fits it.